In an interview, Dr. Rosario Ligresti highlighted what sufferers with gastrointestinal stromal tumors, or GIST, ought to know upon beginning therapy.In an interview...
The FDA accepted the Dako Omnis panel to establish sufferers with colorectal most cancers with mismatch restore deficiency.The mismatch restore immunohistochemical panel pharmDx (Dako Omnis)...